Literature DB >> 8051239

Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays.

L A Magnarelli1, J F Anderson, R C Johnson, R B Nadelman, G P Wormser.   

Abstract

Eight strains of Borrelia burgdorferi sensu lato were tested with serum samples from persons who had Lyme borreliosis or syphilis in class-specific enzyme-linked immunosorbent assays (ELISAs). Antigens of B. burgdorferi sensu stricto, of Borrelia garinii, and of Borrelia spirochetes in group VS461 were prepared from cultured bacteria isolated from ticks, a white-footed mouse (Peromyscus leucopus), or human tissues in North America, the former Soviet Union, and Japan. Nearly all of the serum specimens that contained immunoglobulins to strain 2591, a Connecticut isolate, were also positive in antibody tests with the other seven strains. In general, all eight strains reacted similarly and were suitable as coating antigens in class-specific ELISAs. Assay sensitivities ranged from 82.6 to 100% in analyses for immunoglobulin M and G antibodies. Compared with reference antigen strain 2591, strains 231 (a tick isolate from Canada) and NCH-1 (a human skin isolate from Wisconsin) resulted in higher antibody titers in an ELISA. Syphilitic sera cross-reacted in all tests regardless of the antigen used. Key immunodominant proteins are shared among the closely related strains of B. burgdorferi sensu lato tested, but it is suspected that variations in antigen compositions among these spirochetes may sometimes affect assay performance for detecting serum antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051239      PMCID: PMC263628          DOI: 10.1128/jcm.32.5.1154-1158.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Antibody response against autologous and heterologous isolates of Borrelia burgdorferi in four patients with Lyme neuroborreliosis.

Authors:  M Karlsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

2.  Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin.

Authors:  E Fikrig; E D Huguenel; R Berland; D W Rahn; J A Hardin; R A Flavell
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

3.  Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease.

Authors:  L A Magnarelli; J N Miller; J F Anderson; G R Riviere
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 4.  Epizootiology of Lyme disease and methods of cultivating Borrelia burgdorferi.

Authors:  J F Anderson; L A Magnarelli
Journal:  Ann N Y Acad Sci       Date:  1992-06-16       Impact factor: 5.691

5.  Infectious but nonpathogenic isolate of Borrelia burgdorferi.

Authors:  J F Anderson; S W Barthold; L A Magnarelli
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

6.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

7.  Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease.

Authors:  W Melchers; J Meis; P Rosa; E Claas; L Nohlmans; R Koopman; A Horrevorts; J Galama
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

8.  Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans.

Authors:  D W Dorward; T G Schwan; C F Garon
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

9.  Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis.

Authors:  J Belfaiza; D Postic; E Bellenger; G Baranton; I S Girons
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

10.  Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella.

Authors:  K Hansen; K Pii; A M Lebech
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  15 in total

1.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans.

Authors:  J F Anderson; R A Flavell; L A Magnarelli; S W Barthold; F S Kantor; R Wallich; D H Persing; D Mathiesen; E Fikrig
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; H Krahl; H Peters; V Fingerle; B Wilske
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.

Authors:  C A Wieneke; S D Lovrich; S M Callister; D A Jobe; J A Marks; R F Schell
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii western blots (immunoblots).

Authors:  G L Norman; J M Antig; G Bigaignon; W R Hogrefe
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens.

Authors:  L A Magnarelli; J W Ijdo; S J Padula; R A Flavell; E Fikrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. Valaisiana in humans.

Authors:  K Ryffel; O Péter; B Rutti; A Suard; E Dayer
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

10.  Epidemiological investigation of Borrelia burgdorferi in horses in the municipality of Sinop-MT, Brazil.

Authors:  Suyane Nayara Garcia Socoloski; Bruno Gomes de Castro; Matheus Dias Cordeiro; Adivaldo Henrique da Fonseca; Marcio Barizon Cepeda; Rafael Romero Nicolino; Luciano Bastos Lopes
Journal:  Trop Anim Health Prod       Date:  2018-01-31       Impact factor: 1.559

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.